Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 5 No. 5, May 1996 TABLE OF CONTENTS
  •  Online Features
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Adherence to Single Daily Dose of Aspirin in a Chemoprevention Trial

An Evaluation of Self-report and Microelectronic Monitoring

Kimberly D. Burney, MS, RD; Koyamangalath Krishnan, MD, MRCP; Mack T. Ruffin, MD; Daowen Zhang, MS; Dean E. Brenner, MD

Arch Fam Med. 1996;5(5):297-300.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther. 1989;46:163-168. PUBMED
2. Zelen M. Are primary cancer trials feasible? J Natl Cancer Inst. 1988;80:1442-1444. FREE FULL TEXT
3. Arnold AM, Browman GP, Johnstone B, Skingley P, Booker L, Levine MN. Chemoprevention for lung cancer: evidence for a high degree of compliance. Cancer Detect Prev. 1990;5:521-525.
4. Berenson M, Goshen S, Miller H, Decosse J. Subject-reported compliance in a chemoprevention trial for familial adenomatous polyposis. J Behav Med. 1989;12:233-247. PUBMED
5. Urquhart J. Noncompliance: the ultimate absorption barrier. In: Prescott LF, Nimmo WS, eds. Novel Drug Delivery and Its Therapeutic Application. New York, NY: John Wiley & Sons Inc; 1989:127-137.
6. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oulette V. How often is medication taken as prescribed? a novel assessment technique. JAMA. 1989;261:3273-3277. FREE FULL TEXT
7. Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Messe MR. Patient noncompliance with self-administered chemotherapy. Cancer. 1990;65:17-22. PUBMED
8. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial of pill counts. Clin Pharm Ther. 1989;46:170-176.
9. Waterhouse DM, Calzone KA, Mele C, Brenner, D. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol. 1993;2:1189-1197.
10. Love RR. Prospects for antiestrogen chemoprevention of breast cancer. J Natl Cancer Inst. 1990;82:18-21. FREE FULL TEXT
11. Fischer B, Constantino J, Redmond C. A randomized trial evaluation of tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-positive tumors. N Engl J Med. 1989;320:479-484. ABSTRACT
12. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven Press; 1991:123-137.
13. Maenpaa H, Javela K, Pikkarainen J, Malkonen M, Heinonen OP, Manninen V. Minimal doses of digoxin: a new marker for compliance to medication. Eur Heart J. 1987;8(suppl_1):31-37. FREE FULL TEXT
14. Maenpaa H, Manninen V, Heinonen OP. Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial. Eur Heart J. 1987;8(suppl 1):39-43. FREE FULL TEXT
15. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. J Gerontol. 1987;42:552-557. FREE FULL TEXT
16. Sackett DL. Hypertension in the real world: public reaction, physician response, and patient compliance. In: Genest J, Koiw E, Kuchel O, eds. Hypertension: Physiopathology and Treatment. New York, NY: McGraw-Hill International Inc; 1977:1142-1149.
17. Greenberg ER, Baron JA, Freeman D Jr, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users: the polyp prevention study group. J Natl Cancer Inst. 1983;11:912-916.
18. Paganini-Hill A, Chao A, Ross R, Henderson B. Aspirin use and chronic disease: a cohort study of elderly. BMJ. 1989;6710:127-150.
19. Paganini-Hill A, Hsu G, Ross RK, Henderson BE. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1992;19:1290-1291.
20. Paganini-Hill A. Aspirin and the prevention of colorectal cancer: a review of the evidence. Semin Surg Oncol. 1994;3:158-164.
21. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993;15:1220-1224.
22. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willet WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;4:241-246.
23. Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction: a physicians' health study. Arch Intern Med. 1994;154:2649-2657. FREE FULL TEXT
24. Cramer JA. Identifying and improving compliance patterns: a composite plan for health care providers. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven Press; 1991:387-392.